Pharmaceutical Equipment Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

The Pharmaceutical Equipment Market is Segmented by Type (Weighing Equipment, Lyophilizer, Pharmaceutical Water Equipment, Granulating Equipment, Packaging Equipment, and Other Types), Formulation (Tablets, Capsules, Injectables, and Other Formulations), End User (Pharmaceutical Manufacturing Companies, Contract Manufacturing, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the values (USD million) for the above segments.

Pharmaceutical Equipment Market Size

Pharmaceutical Equipment Market Summary
share button
Study Period 2018-2028
Base Year For Estimation 2022
CAGR 4.60 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Pharmaceutical Equipment Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Pharmaceutical Equipment Market Analysis

The pharmaceutical equipment market is expected to grow at a CAGR of 4.6% over the forecast period.

Due to limitations on medicine production in biotech and pharmaceutical manufacturing facilities, trade restrictions, and a shortage of raw materials, the COVID-19 pandemic had a negative influence on the market in its earliest stages. However, the market recovered in the second phase of the pandemic thanks to the use of pharmaceutical machinery for medications connected to COVID-19 and the initiatives of important market participants. For instance, in May 2022, an article published in the National Library of Medicine stated that lipid nanoparticle (LNP)-formulated nucleoside-modified mRNA vaccines have proven to be very successful in the fight against the COVID-19 pandemic. Thus, the long-term storage of mRNA-LNP vaccines with lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine. Hence, such advantages are expected to increase the market growth. Furthermore, initiatives such as in June 2022, Pfizer announced its commitment to United States manufacturing with a USD 120 million investment at its Kalamazoo, Michigan, facility, enabling United States-based production in support of its COVID-19 oral treatment, PAXLOVID (nirmatrelvir tablets and ritonavir tablets). Thus, such initiatives significantly impacted the market during the COVID-19 pandemic.

Factors such as high growth in the pharmaceutical and biopharmaceutical industry and technological developments are expected to increase market growth. For instance, in March 2022, Japan launched a new research and development center, for USD 1.6 billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. The establishment of an R&D facility for innovative partnerships and budget management will be under Supervisory Control And Data Acquisition (SCADA). Similarly, in December 2021, the Board of Global Alliance for Vaccine and Immunization (Gavi) approved an investment to support the malaria vaccine introduction, procurement, and delivery for Gavi-eligible countries in sub-Saharan Africa in 2022-2025. An initial investment of USD 155.7 million for 2022-2025 will initiate the implementation of this additional tool in the combat against malaria. Thus, such investments by the governments are expected to increase the adoption of pharmaceutical equipment which is expected to increase market growth over the forecast period.

Furthermore, investments by pharmaceutical companies in its production are another factor driving the market growth. For instance, in November 2021, Sartorius invested USD 300 million to launch cell culture media production and assemble sterile systems for efficient and flexible manufacturing of biopharmaceuticals in South Korea. Thus, such initiatives are expected to increase market growth over the forecast period. Similarly, a rise in technological developments based on agreements between industry players is expected to drive market growth. For instance, in July 2021, Huhtamaki and Syntegon agreed to create a paper-based tablet packaging solution for the pharmaceutical and healthcare industries. However, the high cost of equipment is expected to hinder market growth.

Pharmaceutical Equipment Market Trends

Lyophilizer Segment is Expected to be Dominant in Pharmaceutical Equipment Market Over the Forecast Period

A lyophilizer, also known as a freeze dryer, is a device used in laboratory and pharmaceutical settings for preserving and dehydrating perishable materials. The process of lyophilization involves freezing the material, then subjecting it to a high vacuum so that the frozen water in the material sublimes, bypasses the liquid phase, and goes directly from a solid to a gas. This leaves the material in a dry, preserved state that can be stored for long periods without spoilage. Factors such as increasing investment in the pharmaceutical industry coupled with the initiatives by key market players are expected to increase segment growth over the forecast period. For instance, in May 2022, PCI Pharma Services invested USD 100 million in an expansion of capabilities and capacities to its manufacturing facility in Bedford for aseptic liquid fill-finish and sterile lyophilization technology. Also, in May 2022, OPTIMA invested in a state-of-the-art facility to get integrated pharmaceutical lines into production more safely and quickly. Optima Pharma is further expanding the successful CSPE process for fast and safe production start-up of integrated filling lines with isolators and freeze dryers. The rising acceptance of biopharmaceutical manufacturing equipment over the years is expected to increase investment in lyophilizers for the drug manufacturing process thus increasing segment growth over the forecast period.

Also, it is anticipated that throughout the course of the forecast period, the utilization of lyophilizer devices in manufacturing facilities will increase. For instance, to complement its lyophilization research investigations, Berkshire Sterile Manufacturing bought a new IMA lab-scale lyophilizer in April 2022. Thus, it is anticipated that such expenditures by leading market players will fuel industry sector expansion.

Pharmaceutical Equipment Market: Estimated Biopharmaceutical Research and Development Spending (In Billions), Global, 2021-2024

North America has been Dominant in the Pharmaceutical Equipment Market and Similar is Expected Over the Forecast Period

North America is expected to have a significant share of the market owing to factors such as rising research and development activities, the rising approval of biological products, and the strong presence of industry players in the region. For instance, the Florida-based Mettler-Toledo Product Inspection company introduced a new track & trace and Checkweighing combined solution for small and mid-sized enterprises in the pharmaceutical and cosmetics sectors in November 2022. With the support of the Mettler-Toledo CT33 system, operators may accomplish compliance, enhanced brand protection, quality control, and supply chain traceability by having a deep level of integration between mark & verify, serialization, and precision weighing capabilities. The launches of such lyophilization equipment are expected to propel the segment growth during the forecast period.

Similarly, investment by the government in the region is another factor in market growth. For instance, as per the press release by the Government of Canada, in March 2021, it invested more than USD 1 billion in advancing the research and development in pharmaceuticals, biomanufacturing, and vaccines. The government is also exhibiting its continued support for made-in-Canada vaccines and therapeutics to counter COVID-19 with a USD 150 million investment to assist companies in the initial stages of research and development. Likewise, 6 vaccine candidates and 7 therapeutic candidates already received advisory support and funding totaling more than USD 37 million from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). The remaining USD 113 million will be used to advance the most promising of these candidates to the next stage of clinical development, the news release stated. Thus, increasing initiatives such as product launches and investments are expected to increase market growth over the forecast period.

Pharmaceutical Equipment Market - Growth Rate by Region

Pharmaceutical Equipment Industry Overview

The pharmaceutical equipment market is moderately consolidated and consists of several major players. In terms of market share, a few of the major players are currently dominating the market including Alexanderwerk, ALFA LAVAL, GEA Group, Korber AG, and LFA Machines Oxford LTD among others.

Pharmaceutical Equipment Market Leaders

  1. Alexanderwerk

  2. ALFA LAVAL

  3. GEA Group

  4. Korber AG

  5. LFA Machines Oxford LTD

*Disclaimer: Major Players sorted in no particular order

Pharmaceutical Equipment Market Concentration

Pharmaceutical Equipment Market News

  • In November 2022, Telstar expanded the process laboratory service for freeze-drying and sterilization by incorporating cold sterilization methods for non-compatible medical and pharmaceutical products with conventional high-temperature sterilization.
  • In May 2022, Fluid Air technology was developed by Fluid Air, a division of Spraying Systems Co. was selected by research lab Sferalp SA for use in its research laboratory located in Monteggio, Switzerland.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High Growth in Pharmaceutical and Biopharmaceutical Industry

      2. 4.2.2 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Equipment

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Type

      1. 5.1.1 Weighing Equipment

      2. 5.1.2 Lyophilizer

      3. 5.1.3 Pharmaceutical Water Equipment

      4. 5.1.4 Granulating Equipment

      5. 5.1.5 Packaging Equipment

      6. 5.1.6 Others

    2. 5.2 By Formulation

      1. 5.2.1 Tablets

      2. 5.2.2 Capsules

      3. 5.2.3 Injectables

      4. 5.2.4 Other Formulations

    3. 5.3 By End User

      1. 5.3.1 Pharmaceutical Manufacturing Companies

      2. 5.3.2 Contract Manufacturing Companies

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Alexanderwerk

      2. 6.1.2 ALFA LAVAL

      3. 6.1.3 Anchor Mark Pvt Ltd

      4. 6.1.4 Azbil Corporation (Telstar)

      5. 6.1.5 Bausch+Strobel SE + Co. KG

      6. 6.1.6 Spraying Systems Co.

      7. 6.1.7 GEA Group

      8. 6.1.8 Honeyman Group Limited

      9. 6.1.9 Korber AG

      10. 6.1.10 Labconco

      11. 6.1.11 LFA Machines Oxford LTD

      12. 6.1.12 Pharmalab India Pvt. Ltd

      13. 6.1.13 Syntegon Technology GmbH

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

Pharmaceutical Equipment Industry Segmentation

As per the scope, pharmaceutical equipment helps manufacturers in the production of drugs with desired qualities and properties. The Pharmaceutical Equipment Market is Segmented by Type (Weighing Equipment, Lyophilizer, Pharmaceutical Water Equipment, Granulating Equipment, Packaging Equipment, and Others), Formulation (Tablets, Capsules, Injectables, and Other Formulations), End User (Pharmaceutical Manufacturing Companies, Contract Manufacturing, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally. The report offers the values (USD million) for the above segments.

By Type
Weighing Equipment
Lyophilizer
Pharmaceutical Water Equipment
Granulating Equipment
Packaging Equipment
Others
By Formulation
Tablets
Capsules
Injectables
Other Formulations
By End User
Pharmaceutical Manufacturing Companies
Contract Manufacturing Companies
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Pharmaceutical Equipment Market is projected to register a CAGR of 4.6% during the forecast period (2023-2028).

Alexanderwerk, ALFA LAVAL, GEA Group, Korber AG and LFA Machines Oxford LTD are the major companies operating in the Pharmaceutical Equipment Market.

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2023-2028).

In 2023, the North America accounts for the largest market share in the Pharmaceutical Equipment Market.

Pharmaceutical Equipment Industry Report

Statistics for the 2023 Pharmaceutical Equipment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Pharmaceutical Equipment analysis includes a market forecast outlook to for 2023 to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!